| Product No | EMEA/H/C/000309 |
|---|---|
| Brand Name | Toujeo (previously Optisulin) |
| Nonproprietary Name | insulin glargine |
| API | insulin glargine |
| ATC Code | A10AE04 |
| Indications | Treatment of diabetes mellitus in adults, adolescents and children from the age of 6 years. |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | Sanofi-aventis Deutschland GmbH |
| Status | Authorised(授权) |
| Authorization Date | 2000-06-26 |
| Version | 32 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information